NCT00382967View on ClinicalTrials.gov

A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms

PHASE4CompletedINTERVENTIONAL

Enrollment

273

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Parkinsonian Syndromes

Interventions

PROCEDURE

DaTSCAN SPECT imaging

A single intravenous injection of DaTSCAN with a total activity of 111-185 MBq (volume of 2.5 or 5.0 mL). SPECT scanning to be performed 3 to 6 hours after DaTSCAN injection.

Trial Locations (2)

78457

GE Healthcare, Vélizy-Villacoublay

08540

GE Healthcare, Princeton